Dr. Toni Brayer Responds to New FDA Requirement to Lower Zolpidem Doses in Sleeping Medication
Posted on Jan 11, 2013 in Wellness
Dr. Toni Brayer, regional vice president and chief medical officer for Sutter Health, spoke with KPIX-TV San Francisco on the FDA’s latest regulation to lower recommended doses of zolpidem for women. Zolpidem is an active ingredient in Ambien and other sleeping medications.
If you liked this article, you may also like:
Unnecessary Early Deliveries of Babies Reduced Considerably, Study Finds Women’s Health Advocates Say, ‘Put Yourself First in 2013’